Chuvash polycythemia VHLR200W mutation is associated with down-regulation of hepcidin expression.
about
Molecular mechanisms of action and therapeutic uses of pharmacological inhibitors of HIF-prolyl 4-hydroxylases for treatment of ischemic diseasesSuppression of hepcidin expression and iron overload mediate Salmonella susceptibility in ankyrin 1 ENU-induced mutantHIF-prolyl hydroxylases as therapeutic targets in erythropoiesis and iron metabolismAnaemia in kidney disease: harnessing hypoxia responses for therapyHepatic hypoxia-inducible factor-2 down-regulates hepcidin expression in mice through an erythropoietin-mediated increase in erythropoiesisTreatment of erythropoietin deficiency in mice with systemically administered siRNA.HIF2α Is an Essential Molecular Brake for Postprandial Hepatic Glucagon Response Independent of Insulin Signaling.Testosterone administration inhibits hepcidin transcription and is associated with increased iron incorporation into red blood cells.Regulation of erythropoiesis by hypoxia-inducible factorsThe von Hippel-Lindau Chuvash mutation in mice alters cardiac substrate and high-energy phosphate metabolism.Iron homeostasis in the liver.Hypoxia-inducible factors link iron homeostasis and erythropoiesis.Therapeutic targeting of the HIF oxygen-sensing pathway: Lessons learned from clinical studies.The hypoxia-inducible factor-C/EBPα axis controls ethanol-mediated hepcidin repression.Erythropoietin-driven signaling ameliorates the survival defect of DMT1-mutant erythroid progenitors and erythroblastsHypoxia-inducible factor regulates hepcidin via erythropoietin-induced erythropoiesisIron status in patients with pyruvate kinase deficiency: neonatal hyperferritinaemia associated with a novel frameshift deletion in the PKLR gene (p.Arg518fs), and low hepcidin to ferritin ratios.Hypoxia-Inducible Factor and Its Role in the Management of Anemia in Chronic Kidney Disease.
P2860
Q28297656-41F082ED-6347-4636-9866-26316CF4BE12Q28505375-BBB1D017-07E4-456B-B0FD-0A38B457671FQ33926530-6616571E-0F53-4089-A741-A4B21FAD75B0Q35836904-29333A89-B377-4B41-BC0A-72B3680BFFFDQ36006369-CFBD2006-F2EF-4663-A516-2732D5E281CDQ36206440-DC9291DA-3430-4845-97C2-7A9A01F4DF64Q36669733-2DDD2FC0-FFB0-44D2-A21A-C864DC1CC7C6Q36698689-DB13C4CD-4951-419A-90BE-FB8BF1776BC4Q37063716-7AE3FDFA-770A-4952-8CB8-3C06800F9216Q37480834-93F3AFAA-4930-482E-A940-DA197F4C456FQ37605754-7480D5D4-EEFE-4573-A173-135647332574Q37620078-BA9ADCA8-1D70-41BF-8967-06D90F715A9DQ39291945-752587DA-01C1-4CC3-8906-8DEF46F05D4BQ39301385-30DA30E9-6F2D-43D2-9060-F85B2D578F78Q41538643-F3535906-4482-4DCC-ACAE-0D7947C356C3Q42147890-1D062024-0A7F-45EC-9A1D-A4C9D919E92DQ44755026-75BFC1E5-82F9-4357-AD29-F35793DE594BQ48140646-60357640-CB67-4FFD-A8CA-B2385DF777C1
P2860
Chuvash polycythemia VHLR200W mutation is associated with down-regulation of hepcidin expression.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Chuvash polycythemia VHLR200W ...... lation of hepcidin expression.
@ast
Chuvash polycythemia VHLR200W ...... lation of hepcidin expression.
@en
type
label
Chuvash polycythemia VHLR200W ...... lation of hepcidin expression.
@ast
Chuvash polycythemia VHLR200W ...... lation of hepcidin expression.
@en
prefLabel
Chuvash polycythemia VHLR200W ...... lation of hepcidin expression.
@ast
Chuvash polycythemia VHLR200W ...... lation of hepcidin expression.
@en
P2093
P2860
P1433
P1476
Chuvash polycythemia VHLR200W ...... lation of hepcidin expression.
@en
P2093
Adelina I Sergueeva
Daniel J Okhotin
Galina Y Miasnikova
Josef T Prchal
Lydia A Polyakova
Mehdi Nouraie
Sergei Nekhai
Tatiana Ammosova
Victor R Gordeuk
Xiaomei Niu
P2860
P304
P356
10.1182/BLOOD-2011-03-345512
P407
P50
P577
2011-08-29T00:00:00Z